<html><head><meta charset="utf-8"><title>Dashboard MPXV - Synthétique</title><style>body{font-family:Arial;margin:20px;}img{max-width:100%;border:1px solid #ddd;margin:10px 0;}</style></head><body><h1>Dashboard MPXV - Données synthétiques</h1><h2>Surveillance et Diagnostic</h2><h3>01_surveillance_incidence_positivite_semaine.png</h3><img src="01_surveillance_incidence_positivite_semaine.png"><h3>02_diagnostic_positivite_par_type.png</h3><img src="02_diagnostic_positivite_par_type.png"><h2>Infectiosité et Transmission</h2><h3>03a_infectiosite_ct_vs_delai_scatter.png</h3><img src="03a_infectiosite_ct_vs_delai_scatter.png"><h3>03b_infectiosite_ct_vs_delai_box.png</h3><img src="03b_infectiosite_ct_vs_delai_box.png"><h3>09_infectiosite_nb_localisations_lesions.png</h3><img src="09_infectiosite_nb_localisations_lesions.png"><h3>10_transmission_positivite_par_mobilite.png</h3><img src="10_transmission_positivite_par_mobilite.png"><h3>13_transmission_nb_localisations_par_charge_virale.png</h3><img src="13_transmission_nb_localisations_par_charge_virale.png"><h2>Identification et Risques</h2><h3>04_identification_nb_symptomes_par_statut.png</h3><img src="04_identification_nb_symptomes_par_statut.png"><h3>05_risques_severite_par_vih.png</h3><img src="05_risques_severite_par_vih.png"><h3>08_qualite_indices_preanalytiques.png</h3><img src="08_qualite_indices_preanalytiques.png"><h3>12_vulnerabilites_severite_par_age.png</h3><img src="12_vulnerabilites_severite_par_age.png"><h2>Prévention et Démographie</h2><h3>06_prevention_positivite_par_vaccin.png</h3><img src="06_prevention_positivite_par_vaccin.png"><h3>07_demographie_age_par_statut.png</h3><img src="07_demographie_age_par_statut.png"><h3>11_ciblage_positivite_par_age.png</h3><img src="11_ciblage_positivite_par_age.png"><h3>14_demographie_positivite_par_sexe.png</h3><img src="14_demographie_positivite_par_sexe.png"></body></html>